· Health Care Equipment · S&P 500
BAX BAXTER INTERNATIONAL $12.0B
No on this lens. Connected care is the device line. AI is still exploration.
4 of 15
Reach, Weight, and Proof.
Last updated score 31 AugLast review 29 OctLast earnings call 29 OctNext earnings call not posted yet
What they are doing
Baxter's growth story in the latest quarter is connected devices: patient support, Connex 360 monitoring, and the Dynamo stretcher. The annual report treats artificial intelligence separately, as a thoughtful exploration inside operational excellence, plus a risk factor. That is not a named product in the offer. The 29 October 2026 call, including the questions, named no artificial-intelligence feature on a bed, pump, or monitor. The score stays 4.
Why the score
- Reach 1 not 2: one line about exploring AI for how they run the company. Not a second function.
- Weight 1 not 2: exploration, not a live hygiene tool they have named in production.
- Proof 2 not 1: the annual report names the exploration and ties it to operations.
- Proof 2 not 3: nothing you can see running as an AI product.
What would move it next quarter: A named AI feature on a bed, pump, or monitor, with a use you can point to.
Open these first
Evidence
Operational excellence includes increased automation and digitization, including thoughtful exploration of artificial intelligence initiatives. A separate risk says incorporating AI into products and operations could affect the business. Exploration, not a launched product.
Healthcare Systems and Technologies sales were about 801 million dollars, up 4 percent, on patient support systems and front line care. The release does not name an AI product.